Cgmp Regulations

FDA
Manufacturing

FDA slaps Aurobindo with warning letter on API testing failures

The FDA slapped Aurobindo Pharma with a warning letter for failing to adequately investigate batch failures of APIs and inadequate evaluations.
Joseph Keenan Jan 27, 2022 10:50am
Hammer

FDA hammers another Aurobindo plant for flawed data integrity

Jun 12, 2019 10:11am
Chongqing China

Fosun Pharma accused of ‘massively’ faking production data

Aug 31, 2018 11:03am
EU flag depature

Regulators again pull EuropharmaDK’s manufacturing authorization

Nov 8, 2017 11:45am
FDA

FDA hits China’s Foshan Flying Medical with warning letter

Aug 17, 2017 8:15am
cosmetics bottles

China facility of Ausmetics hit with FDA warning letter

Feb 15, 2017 2:51pm